Proteoglycan compositions for treating arthritic inflammatory conditions
OwnerTheoharis C. Theoharidesinventor
Life of this patent
Estimating the term…
Abstract
Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, non-bovine proteoglycan such as shark cartilage chondroitin sulfate C, and one or more of a hexosamine sulfate such as D-glucosamine sulfate, a flavone such as quercetin, an unrefined olive kernel extract that increases absorption of these compositions in various routes of administration, S-adenosylmethionine, a histamine-1 receptor antagonist, a histamine-3 receptor agonist, an antagonist of the actions of CRH, caffeine, and a polyamine.
Claims1
A composition for topical use with synergistic anti-inflammatory properties in arthritis conditions induced by the activation of mast cells, consequent degranulation of said cells and subsequent secretion of inflammatory biomolecules, comprising a skin cream comprising:
- shark cartilage chondroitin sulfate, 0.1%;
- Saphona plant quercetin, 0.5%;
- shellfish chitin D-glucosamine sulfate, 0.05%;
- Bitter Willow Bark Extract, 0.1%;
- KCl, 0.01%;
- NaCl, 0.025%;
- MgCl2, 0.07%;
- sodium dibasic phosphate, 0.002%;
- microfiltered olive kernel (pit) extract (acidity less than 3% and water less than 5%), 10% ;
- TiO2, 1%;
- camphor, 0.05%;
- oregano oil, 0.02%;
- sodium benzoate as preservative;
- and Adagio floral fragrance.
Dependencies are inferred from the claim text.